A meta-analysis of the safety and effectiveness of pemetrexed compared with gefitinib for pre-treated advanced or metastatic NSCLC

BACKGROUND: The purpose of the current meta-analysis was to compare the oncological outcomes of pemetrexed versus gefitinib in pre-treated advanced or metastatic non-small cell lung cancer (NSCLC) patients. METHODS: Search the online electronic databases on comparison the effectiveness and adverse e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xiaoxin, Li, Shengshu, Chen, Weizong, Zheng, Dongyang, Li, Yuzhu, Li, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373595/
https://www.ncbi.nlm.nih.gov/pubmed/32702875
http://dx.doi.org/10.1097/MD.0000000000021170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373595/
https://www.ncbi.nlm.nih.gov/pubmed/32702875
http://dx.doi.org/10.1097/MD.0000000000021170

Ejemplares similares